Advanced search
Publication Cover
Cancer Management and Research Volume 10, 2018 - Issue
Submit an article Journal homepage
68
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival

Thomas Greither1 Center for Reproductive Medicine and Andrology, Martin Luther University Halle-Wittenberg, Halle, Germany
,
Kersten Fischer2 Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany
,
Gerit Theil2 Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany
,
Marios Marcou1 Center for Reproductive Medicine and Andrology, Martin Luther University Halle-Wittenberg, Halle, Germany;2 Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany
,
Hans-Juergen Holzhausen3 Department of Pathology, Martin Luther University Halle-Wittenberg, Halle, Germany
,
Katrin Weigelt4 Department of Urology and Pediatric Urology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, [email protected]
,
Ginette Serrero5 A&G Pharmaceutical Inc., Columbia, Maryland, USA;6 Program in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA
,
David Hicks5 A&G Pharmaceutical Inc., Columbia, Maryland, USA
,
Binbin Yue5 A&G Pharmaceutical Inc., Columbia, Maryland, USA
,
Paolo Fornara2 Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany
,
Bernd Wullich4 Department of Urology and Pediatric Urology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, [email protected]
,
Helge Taubert4 Department of Urology and Pediatric Urology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, [email protected]Correspondence[email protected]
,
Sven Wach4 Department of Urology and Pediatric Urology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, [email protected]
&
Verena Lieb4 Department of Urology and Pediatric Urology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany, [email protected]
 show all
Pages 4173-4180 | Published online: 05 Oct 2018

References

  • ZhangHPanCXChengLGRN (granulin)Atlas Genet Cytogenet Oncol Haematol200812208212
  • BhandariVPalfreeRGBatemanAIsolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domainsProc Natl Acad Sci U S A1992895171517191542665
  • BatemanABennettHPThe granulin gene family: from cancer to dementiaBioessays200931111245125419795409
  • SerreroGAutocrine growth factor revisited: PC-cell-derived growth factor (progranulin), a critical player in breast cancer tumorigenesisBiochem Biophys Res Commun2003308340941312914763
  • TangkeangsirisinWHayashiJSerreroGPC cell-derived growth factor mediates tamoxifen resistance and promotes tumor growth of human breast cancer cellsCancer Res20046451737174314996734
  • KimWESerreroGPC cell-derived growth factor stimulates proliferation and confers Trastuzumab resistance to Her-2-overexpressing breast cancer cellsClin Cancer Res20061214 Pt 14192419916857791
  • WangWHayashiJSerreroGPC cell-derived growth factor confers resistance to dexamethasone and promotes tumorigenesis in human multiple myelomaClin Cancer Res2006121495616397023
  • AbrhaleTBrodieASabnisGGP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cellsBMC Cancer20111123121658239
  • KudohKRamannaMRavatnRMonitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarrayCancer Res200060154161416610945624
  • HanJJYuMHoustonNSteinbergSMKohnECProgranulin is a potential prognostic biomarker in advanced epithelial ovarian cancersGynecol Oncol2011120151020950846
  • TkaczukKRYueBZhanMIncreased circulating level of the survival factor GP88 (Progranulin) in the serum of breast cancer patients when compared to healthy subjectsBreast Cancer2011515516221792312
  • YamamotoYTakemuraMSerreroGIncreased serum GP88 (Progranulin) concentrations in rheumatoid arthritisInflammation20143751806181324803297
  • YamamotoYGotoNTakemuraMAssociation between increased serum GP88 (progranulin) concentrations and prognosis in patients with malignant lymphomasClin Chim Acta201747313914628823651
  • EdelmanMJFelicianoJYueBGP88 (progranulin): a novel tissue and circulating biomarker for non-small cell lung carcinomaHum Pathol20144591893189925033727
  • KooDHParkCYLeeESRoJOhSWProgranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort studyPLoS One201276e3988022761921
  • MonamiGEmiliozziVBittoAProepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growthAm J Pathol200917431037104719179604
  • PanCXKinchMSKienerPAPC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinomaClin Cancer Res20041041333133714977833
  • WachSAl-JanabiOWeigeltKThe combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancerInt J Cancer201513761406141625754273
  • TanimotoRLuKGXuS-QMechanisms of progranulin action and regulation in genitourinary cancersFront Endocrinol2016717
  • AbellaVPinoJScoteceMProgranulin as a biomarker and potential therapeutic agentDrug Discov Today201722101557156428651064
  • Arechavaleta-VelascoFPerez-JuarezCEGertonGLDiaz-CuetoLProgranulin and its biological effects in cancerMed Oncol2017341219429116422
  • SerreroGPotential of theranostic target mining in the development of novel diagnostic and therapeutic products in oncology: progranulin/GP88 as a therapeutic and diagnostic target for breast and lung cancersRinsho Byori20166412961309
  • BuraschiSXuSQStefanelloMSuppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatinOncotarget2016726399803999527220888

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.